Wordt geladen...
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases
Clinical development of bromodomain and extra‐terminal (BET) protein inhibitors differs from the traditional course of drug development. These drugs are simultaneously being evaluated for treating a wide spectrum of human diseases due to their novel mechanism of action. BET proteins are epigenetic “...
Bewaard in:
| Gepubliceerd in: | Med Res Rev |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7756446/ https://ncbi.nlm.nih.gov/pubmed/32926459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/med.21730 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|